Literature DB >> 6988969

Eosinophilic fasciitis.

T L Moore, J Zuckner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6988969     DOI: 10.1016/0049-0172(80)90009-8

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  9 in total

Review 1.  Eosinophilic Skin Diseases: A Comprehensive Review.

Authors:  Hai Long; Guiying Zhang; Ling Wang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

2.  Massive eosinophilia in rheumatoid arthritis: report of four cases.

Authors:  P T Dawes; D H Smith; D L Scott
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

3.  Diffuse fasciitis.

Authors:  M M Steven; A Cats
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

4.  Treatment with cimetidine of atypical fasciitis panniculitis syndrome.

Authors:  J E Naschitz; D Yeshurun; I Rosner; J E Abrahamson; I Misselevitch; J H Boss
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

5.  [Eosinophilic fasciitis (Shulman syndrome)].

Authors:  P Herzer; H S Füessl; M Meurer; M Schattenkirchner
Journal:  Klin Wochenschr       Date:  1982-11-02

6.  Eosinophilic fasciitis presenting with a reactive hepatitis.

Authors:  A E Loeliger; H R van den Brink; R H Derksen; J W Bijlsma
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

7.  Diffuse (eosinophilic) fasciitis. A series of six cases.

Authors:  J M De Jonge-Bok; M M Steven; F Eulderink; A Cats
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

8.  Chronic progressive eosinophilic fasciitis: report of a 20-year failure to attain remission.

Authors:  R Bertken; D Shaller
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

9.  The incidence of microaneurysms in polyarteritis nodosa.

Authors:  R J Sellar; I G Mackay; T A Buist
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.